BEUT (Science to Consumers) Notes Receivable: $0.00 Mil (As of Feb. 2017)


What is Science to Consumers Notes Receivable?

Science to Consumers BEUT Notes Receivable is $0.00 Mil as of Feb. 2017.

Science to Consumers's Notes Receivable for the quarter that ended in Feb. 2017 was $0.00 Mil.

Science to Consumers Notes Receivable Related Terms

Science to Consumers Notes Receivable Historical Data

* Premium members only.

The historical data trend for Science to Consumers's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Science to Consumers Notes Receivable Chart

Science to Consumers Annual Data
Trend May13 May14 May15 May16
Notes Receivable
0.00 0.00 0.00 0.00

Science to Consumers Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Science to Consumers Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Science to Consumers (BEUT) has a Notes Receivable of $0.00 Mil as of Feb. 2017. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Science to Consumers and its competitors.
Is Science to Consumers' Notes Receivable too high?
Science to Consumers' current Notes Receivable is $0.00 Mil.
How does Science to Consumers' Notes Receivable compare to CAWW and TECR?
Science to Consumers' Notes Receivable of $0.00 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Consumer Packaged Goods company?
A good Notes Receivable depends on the Consumer Packaged Goods industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Science to Consumers and its competitors. Science to Consumers's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Science to Consumers stock overvalued right now?
Science to Consumers (BEUT) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Science to Consumers (BEUT), the current Notes Receivable is $0.00 Mil as of Feb. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Science to Consumers Business Description

Address 555 Ren Min Road, Room 1618, American Bank Centre, Guangzhou, CHN
Science to Consumers Inc is engaged in the development of anti-aging products. Its products include Dermalastyl Facial Scrub, Dermalastyl Bx Pro, Dermalastyl Bx Elastropin, Dermalastyl-e Intensive Eye Serum, Dermalastyl-m Wrinkle Eye Radicator, Dermalastyl-m Anti- Wrinkle after-shave for Men. The company provides direct-to-consumer sales, marketing and distribution of finished consumer skin care products provided by Protein Genomics via direct response advertisements and other globally marketing and distribution channels.